Clemex Discloses Second Quarter Results

11% increase in sales with more than $100,000 Net Profit

Symbol:  CXG.A-CDNX www.clemex.com Shares Outstanding:  30,999,810

MONTREAL, Dec. 14, 2012 /CNW Telbec/ - Clemex Technologies Inc. (TSXV: CXG.A), designer and manufacturer of Image Analysis systems and software for microscopy applications, announces its financial results for the second Quarter of FY2013 ending October 31(st), 2012. For this second Quarter, sales reached $1,570,451 an increase of 11% compared to the same period last year. The Corporation ends this quarter with a Net Profit of $101,047 compared to a Net Profit of $12,004 posted last year. As for the first six month period of FY2013, sales reached $2,875,603 compared to $2,655,142 last year while the Company posted a Net Profit of $56,782 compared to a Net Loss of $34,243 for the same period last year.

During this past Quarter, the Corporation made several sales to clients in the manufacturing sector in North America: Teutech Industries, Ontario, Canada, Nitrex Metal, Quebec, Canada, Total Petrochemicals, Texas (USA), Gerdau, Arkansas (USA), Steel Dynamics, IN (USA) and Raytheon Company, Texas (USA).  As for the International side, the Corporation made substantial sales to General Motors, Mexico, NRB Bearings India and to Hyundai Motors, South Korea.

FINANCIAL HIGHLIGHTS   

                                    Quarter            Semester
           Fiscal Years         2013      2012      2013      2012
                                 $         $         $         $

Sales                      1,570,451 1,414,314 2,875,603 2,655,142
                                                                  

Gross Margin                 877,067   761,339 1,541,933 1,429,510

Gross Margin %                 55.8%     53.8%     53.6%     53.8%

Total Operating Expenses     728,520   712,335 1,412,151 1,398,753
                                                                  

Income Taxes                  47,500    37,000    73,000    65,000
                                                                  

Net Profit(Loss)             101,047    12,004    56,782  (34,243)
                                                                  

Net Profit(Loss) per share     0.003     0.001     0.002   (0.002)

Clement Forget, President and CEO of Clemex Technologies Inc. declared: "We 
are quite pleased with the results of this second Quarter of 2013. Clemex had 
reasonable success in the manufacturing sector in the USA where the automotive 
industry continues to perform well since the beginning of the year. We have 
also concluded important sales in the steel manufacturing industries, a sector 
of activity that had declined in the last few years. Finally, sales of our 
MicroHardness Testers, the Clemex CMT.HD keep up at a steady rate, confirming 
that Clemex is definitely offering one of the best instruments on worldwide 
market for this field of application.

The CEO continued "Sales for this Quarter are in line with our internal 
forecasts and take us back to profitability.  While we work on keeping 
expenses under control, we invest more in marketing activities in view of the 
introduction of the new line of instruments for Hematology which should occur 
within the next six months. Concerning this matter, Clemex along with its 
French partner RAL Diagnostics participated at one of most important Medical 
instruments Trade show in the world, Medica in Düsseldorf, Germany this past 
November where we introduced our latest instrument, the HemaCyto 2L and the 
interest from the show attendees was extremely positive.  We have also just 
exhibited the same instrument this week in Atlanta GA, USA, at the ASH 
(American Society for Hematology) conference where we also had an excellent 
response from the American Medical community. Our R & D team is working very 
hard to fine tune the last details of the instruments while a three month 
validation period will be required before the official launching".

About Clemex Technologies, Inc.

Clemex Technologies Inc. develops, manufactures and markets image analysis 
systems and software used by quality control and research microscopy 
laboratories. Clemex' customer base spans over many countries in America, 
Europe, Asia and encompasses major Research and Development Centers, 
prestigious Universities and large manufacturing industries in various fields 
including healthcare, automotive, aerospace, raw materials manufacturing, 
pharmaceuticals, mining and other sectors.

The CDNX has not reviewed and does not accept responsibility for the adequacy 
and accuracy of this press release. 

 

CLEMEX TECHNOLOGIES INC,  800 Guimond, Longueuil, QC, Canada J4G 1T5,

Contact:

Clément Forget, President and CEO Tel: 450.651.6573 Email: ir@clemex.com

SOURCE: CLEMEX TECHNOLOGIES INC.

To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/December2012/14/c9267.html

CO: CLEMEX TECHNOLOGIES INC.
ST: Quebec
NI: SOF ERN 

-0- Dec/14/2012 19:39 GMT